The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease

Completed

Conditions studied: Alzheimer's Disease, Agitation

In brief

The purpose of this clinical research study is to determine if a specific genetic allele is involved with the development of agitation in patients with late-onset Alzheimer's Disease (AD). The study will compare the results of genetic testing between two groups: individuals with late-onset AD who show signs of agitation and individuals with late-onset AD who do not show signs of agitation.

Key facts

Study ID

NCT01329536

Run by

Avera McKennan Hospital & University Health Center

People needed

50

Starts

2010-12-01

Expected to finish

2011-10-01

Last updated by the study team

2011-10-06

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women who are at least 65 years of age
• Meet the DSM-IV-TR criteria for late-onset Alzheimer's Disease (AD)

You may not qualify if…

• Unable to provide informed consent or do not have a legally acceptable caregiver and/or representative present or available to enter into the informed consent process on the study subject's behalf
• Diagnosis of a non-Alzheimer's type of dementia
• Determined by the Principal Investigator (or his designee) that the study subject would be unsuitable for study participation

Where it is running

• Avera Research Institute — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.